Charles G O'Bryan-Tear

Follow
Get notifications in MyBN when activity occurs.
Subscribe to BN Log In
Charles G O'Bryan-Tear
Non-Executive Director / Clarity Pharmaceuticals

Dr O'Bryan-Tear has over 30 years of experience in the pharmaceutical industry in clinical development, medical management and commercial roles. He has held senior leadership roles in large and small pharmaceutical and biotech companies in the US and Europe and has been involved in multiple product approvals. He was previously the Chief Medical Officer of Algeta ASA. Dr O'Bryan-Tear has been an adviser to several US and European biotech companies and is a member of the Scientific Advisory Boards of Audentes, Inc. (US) and Fusion Pharmaceuticals Inc. (Canada).

Lists and Charts

Total Shareholder Return as at 02/12/24

Rank Company 1 Yr 5 Yr
19th Petratherm 360.61% 40.77%
20th Chilwa Minerals 357.87% 0%
21st Clarity Pharmaceuticals 351.19% 0%
22nd Trigg Minerals 349.92% -8.68%
23rd Rimfire Pacific Mining 340.24% 85.63%
View Full List
1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

22/06/22
$53.40k Bought
Clarity Pharmaceuticals
Total value as at the date of the transaction
Powered by Morningstar ®

Person Activity

 NEW ROLE: Non-Executive Director, Clarity Pharmaceuticals 07 Apr 2022

Related Information

Access to our data for Charles G O'Bryan-Tear is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Charles G O'Bryan-Tear is linked to 1 organisation which is included in 1 list - Public Companies - non WA.

To see the data you will need to Subscribe.

X